Heterogeneity of Germline Variants in High Risk Breast and Ovarian Cancer Susceptibility Genes in India

Precision Clinical Medicine
doi 10.1093/pcmedi/pby010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Germline Variants in Cancer Genes in High-Risk Non-Brca Patients From Puerto Rico

Scientific Reports
Multidisciplinary
2019English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Tumor Sequencing Is Useful to Refine the Analysis of Germline Variants in Unexplained High-Risk Breast Cancer Families

Breast Cancer Research
Cancer ResearchOncology
2020English

Germline Variants in DNA Repair Genes Associated With Hereditary Breast and Ovarian Cancer Syndrome: Analysis of a 21 Gene Panel in the Brazilian Population

BMC Medical Genomics
Genetics
2020English

Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India

Cancer Management and Research
Oncology
2018English

Clinical Implications of Germline Mutations in Breast Cancer Genes: RECQL

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

Variants of Estrogen-Related Genes and Breast Cancer Risk in European and African American Women

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Germline Loss-Of-Function Variants in the BARD1 Gene Are Associated With Early-Onset Familial Breast Cancer but Not Ovarian Cancer

Breast Cancer Research
Cancer ResearchOncology
2019English

Germline Missense Variants in the BTNL2 Gene Are Associated With Prostate Cancer Susceptibility

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy